Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Shares Repurchased (2022 - 2024)

Standard Biotools (LAB) has disclosed Shares Repurchased for 3 consecutive years, with $29.4 million as the latest value for Q2 2024.

  • Quarterly Shares Repurchased rose 1126.62% to $29.4 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $29.4 million through Mar 2025, up 109.9% year-over-year, with the annual reading at $40.5 million for FY2024, 647.88% up from the prior year.
  • Shares Repurchased for Q2 2024 was $29.4 million at Standard Biotools, up from $11.1 million in the prior quarter.
  • The five-year high for Shares Repurchased was $29.4 million in Q2 2024, with the low at $174000.0 in Q4 2023.
  • Average Shares Repurchased over 3 years is $6.6 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Shares Repurchased plummeted 69.09% in 2023, then soared 1126.62% in 2024.
  • Over 3 years, Shares Repurchased stood at $563000.0 in 2022, then tumbled by 69.09% to $174000.0 in 2023, then soared by 16818.97% to $29.4 million in 2024.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $29.4 million, $11.1 million, and $174000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.